NCT02693600

Brief Summary

  1. 1.Introduction:
  2. 2.Objectives and Hypothesis:
  3. 3.Methodology:

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 26, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

June 8, 2017

Status Verified

June 1, 2017

Enrollment Period

1.4 years

First QC Date

February 17, 2016

Last Update Submit

June 7, 2017

Conditions

Keywords

Total TrapeziectomyPartial TrapeziectomyLigamentoplasty

Outcome Measures

Primary Outcomes (1)

  • Changes in the pollicis-lateral pinch strength

    In kilograms and measured with dynamometer.

    Before, three Months and One year after surgery.

Secondary Outcomes (4)

  • Changes in pain score assessed with E.V.A Scale

    Before, three Months and One year after surgery.

  • Changes in range of motion

    Before, three Months and One year after surgery.

  • Changes in Collapse of the first column of thumb using calibrated radiographic analysis

    Before, three Months and One year after surgery.

  • Changes in Quality of life assessed with the Disabilities of the arm, shoulder and hand questionnaire (DASH questionnaire)

    Before, three Months and One year after surgery.

Study Arms (2)

Partial Trapeziectomy (PT)

ACTIVE COMPARATOR

Patients with Osteoarthritis of the trapeziometacarpal joint determined by the classification of Eaton-Littler (stages II-III) treated with with ligamentoplasty and partial trapeziectomy.

Procedure: Ligamentoplasty with partial trapeziectomy

Total Trapeziectomy (TT)

ACTIVE COMPARATOR

Patients with Osteoarthritis of the trapeziometacarpal joint determined by the classification of Eaton-Littler (stages II-III) treated with ligamentoplasty and total trapeziectomy.

Procedure: Ligamentoplasty with total trapeziectomy

Interventions

Partial Trapeziectomy (PT)
Total Trapeziectomy (TT)

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Osteoarthritis in the trapeziometacarpal joint determined by the classification of Eaton-Littler (stages II-III) with trapeziometacarpal joint pain, loss of function, that were included in surgical waiting list and have accepted under informed consent, including the study.

You may not qualify if:

  • Patients with osteoarthritis Eaton-Littler (stage IV).
  • Patients with huge affection of trapezium subchondral cysts and poor quality of trabecular bone.
  • Cognitive impairment.
  • Old fracture with impairment of the same extremity.
  • Rheumatic active illness.
  • Patients who withdraw their informed consent, or in case of impossibility of opinion by clinical status, whose legal guardians or close relatives to withdraw their informed consent to participate in the study.
  • Patients who for any reason not related to the indication needed discontinue study participation or impossible to carry out assessments under more than two follow-up visits.
  • Patients in whom it is considered that participation in the clinical study can be a prejudice, the physician responsible for patient care opinion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Parc Taulí

Sabadell, Barcelona, 08208, Spain

Location

Study Officials

  • Ricard Sánchez-Flo, MD

    Hospital Universitario Parc Taulí de Sabadell

    STUDY DIRECTOR
  • Ferran Fillat-Gomà, MD

    Hospital Universitario Parc Taulí de Sabadell

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MSc

Study Record Dates

First Submitted

February 17, 2016

First Posted

February 26, 2016

Study Start

September 1, 2014

Primary Completion

February 1, 2016

Study Completion

March 1, 2017

Last Updated

June 8, 2017

Record last verified: 2017-06

Locations